LB Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	354	-	-
Enterprise Value	344	-25	-43
EV/EBITDA Ratio	-	0.40	29.96
EV/EBIT Ratio	-	0.39	29.88
EV/FCF Ratio	-	0.46	3.57
Debt / Equity Ratio	-0.04	-0.04	-
Debt / EBITDA Ratio	-	-0.06	-
Debt / FCF Ratio	-	-0.07	-
Quick Ratio	3.77	3.51	16.61
Current Ratio	3.78	3.56	17.51
Interest Coverage	-	-	-0.30
Return on Equity (ROE)	-	97.80%	-
Return on Assets (ROA)	-	-159.40%	-
Return on Capital (ROIC)	-	71.36%	33.00%
Return on Capital Employed (ROCE)	-	-248.18%	-3.37%
Buyback Yield / Dilution	-0.87%	-27.01%	-
Total Shareholder Return	-0.87%	-27.01%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).